📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioVex

1.1 - Company Overview

BioVex Logo

BioVex

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biological treatments for cancer and infectious diseases, focused on development and commercialization. Its cancer program includes OncoVEXGM-CSF, an oncolytic vaccine/cancer-destroying virus that replicates and spreads within solid tumors, causing tumor destruction, and it advances biological treatments for the prevention of infectious disease.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioVex

Linnaeus Therapeutics Logo

Linnaeus Therapeutics

HQ: United States Website
  • Description: Provider of development-stage cancer therapeutics, including LNS8801, an orally bioavailable, highly specific G protein-coupled estrogen receptor (GPER) agonist that depletes c-Myc protein levels, shows antitumor activities in preclinical cancer models, and is being tested in clinical trials as a monotherapy and with pembrolizumab.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Linnaeus Therapeutics company profile →
Auron Therapeutics Logo

Auron Therapeutics

HQ: United States Website
  • Description: Provider of cancer therapeutics focused on transforming malignant cells toward more normal function. Offerings include AURIGIN, an AI/ML platform to identify and target drivers of tumor cell plasticity and altered cellular states in cancer, and AUTX-703, an orally available small molecule therapy targeting KAT2A/B for small cell lung cancer, neuroendocrine prostate cancer, and acute myeloid leukemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Auron Therapeutics company profile →
ProCure Logo

ProCure

HQ: United States Website
  • Description: Provider of a network of proton therapy centers in the United States, offering proton therapy including pencil beam scanning; physician case evaluations; initial consultation and planning; treatment sessions typically 5 days a week for 4–7 weeks; and regular radiation oncologist check-ins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProCure company profile →
Predilife Logo

Predilife

HQ: France Website
  • Description: Provider of predictive medicine solutions that combine proven medical techniques (genetic testing, medical imaging) with mathematical models and extensive statistical data to assess individual risk profiles for serious diseases. Offers a breast cancer five-year risk assessment with personalized follow-up and recommendations, and multi-pathology assessments for major cancers and cardiovascular diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Predilife company profile →
Oncovision Logo

Oncovision

HQ: Mexico Website
  • Description: Provider of molecular vision solutions for the health sciences sector, supporting cancer diagnosis and treatment and advanced research in neurology, oncology, and cardiology. Spanish technology start-up founded in 2003 by the Corpuscular Physics Institute (CSIC) and the University of Valencia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oncovision company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioVex

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioVex

2.2 - Growth funds investing in similar companies to BioVex

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioVex

4.2 - Public trading comparable groups for BioVex

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioVex

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioVex

What does BioVex do?

BioVex is a provider of biological treatments for cancer and infectious diseases, focused on development and commercialization. Its cancer program includes OncoVEXGM-CSF, an oncolytic vaccine/cancer-destroying virus that replicates and spreads within solid tumors, causing tumor destruction, and it advances biological treatments for the prevention of infectious disease.

Who are BioVex's competitors?

BioVex's competitors and similar companies include Linnaeus Therapeutics, Auron Therapeutics, ProCure, Predilife, and Oncovision.

Where is BioVex headquartered?

BioVex is headquartered in United Kingdom.

How many employees does BioVex have?

BioVex has 1,000 employees 🔒.

When was BioVex founded?

BioVex was founded in 2010 🔒.

What sector and industry vertical is BioVex in?

BioVex is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioVex

Who are the top strategic acquirers in BioVex's sector and industry

Top strategic M&A buyers and acquirers in BioVex's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioVex?

Top strategic M&A buyers groups and sectors for BioVex include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioVex's sector and industry vertical

Which are the top PE firms investing in BioVex's sector and industry vertical?

Top PE firms investing in BioVex's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioVex's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioVex's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioVex's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioVex include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioVex's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioVex?

The key public trading comparables and valuation benchmarks for BioVex include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioVex for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioVex with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioVex's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioVex with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioVex's' sector and industry vertical?

Access recent funding rounds and capital raises in BioVex's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioVex